135 related articles for article (PubMed ID: 36877278)
1. Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women.
Løfling L; Støer NC; Nafisi S; Ursin G; Hofvind S; Botteri E
Eur J Epidemiol; 2023 Apr; 38(4):413-426. PubMed ID: 36877278
[TBL] [Abstract][Full Text] [Related]
2. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
Löfling LL; Støer NC; Andreassen BK; Ursin G; Botteri E
Breast Cancer Res; 2023 Aug; 25(1):101. PubMed ID: 37649039
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic aspirin intake and breast cancer risk; A systematic review and meta-analysis of observational cohort studies.
Bakierzynska M; Cullinane MC; Redmond HP; Corrigan M
Eur J Surg Oncol; 2023 Oct; 49(10):106940. PubMed ID: 37321932
[TBL] [Abstract][Full Text] [Related]
4. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
5. Low-Dose Aspirin Reduces Breast Cancer Risk in Women with Diabetes: A Nationwide Retrospective Cohort Study in Taiwan.
Yang YS; Kornelius E; Chiou JY; Lai YR; Lo SC; Peng CH; Huang CN
J Womens Health (Larchmt); 2017 Dec; 26(12):1278-1284. PubMed ID: 28537451
[TBL] [Abstract][Full Text] [Related]
6. Aspirin use and risk of breast cancer in African American women.
Bertrand KA; Bethea TN; Gerlovin H; Coogan PF; Barber L; Rosenberg L; Palmer JR
Breast Cancer Res; 2020 Sep; 22(1):96. PubMed ID: 32887656
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.
Marshall SF; Bernstein L; Anton-Culver H; Deapen D; Horn-Ross PL; Mohrenweiser H; Peel D; Pinder R; Purdie DM; Reynolds P; Stram D; West D; Wright WE; Ziogas A; Ross RK
J Natl Cancer Inst; 2005 Jun; 97(11):805-12. PubMed ID: 15928301
[TBL] [Abstract][Full Text] [Related]
8. Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC).
Zeinomar N; Knight JA; Genkinger JM; Phillips KA; Daly MB; Milne RL; Dite GS; Kehm RD; Liao Y; Southey MC; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; John EM; MacInnis RJ; Hopper JL; Terry MB
Breast Cancer Res; 2019 Nov; 21(1):128. PubMed ID: 31779655
[TBL] [Abstract][Full Text] [Related]
9. Measured adolescent body mass index and adult breast cancer in a cohort of 951,480 women.
Keinan-Boker L; Levine H; Derazne E; Molina-Hazan V; Kark JD
Breast Cancer Res Treat; 2016 Jul; 158(1):157-167. PubMed ID: 27306419
[TBL] [Abstract][Full Text] [Related]
10. Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women.
Cairat M; Al Rahmoun M; Gunter MJ; Severi G; Dossus L; Fournier A
Breast Cancer Res; 2020 Oct; 22(1):118. PubMed ID: 33129324
[TBL] [Abstract][Full Text] [Related]
11. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and Vitamin D-binding protein and risk of bladder cancer: A nested case-control study in the Norwegian Janus Serum Bank Cohort.
Hektoen HH; Robsahm TE; Stenehjem JS; Axcrona K; Babigumira R; Mondul AM; Gislefoss RE; Andreassen BK
Cancer Med; 2021 Jun; 10(12):4107-4116. PubMed ID: 34080787
[TBL] [Abstract][Full Text] [Related]
13. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
Kehm RD; Hopper JL; John EM; Phillips KA; MacInnis RJ; Dite GS; Milne RL; Liao Y; Zeinomar N; Knight JA; Southey MC; Vahdat L; Kornhauser N; Cigler T; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; Daly MB; Terry MB
Breast Cancer Res; 2019 Apr; 21(1):52. PubMed ID: 30999962
[TBL] [Abstract][Full Text] [Related]
14. Association of Nongenetic Factors With Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort.
Al Ajmi K; Lophatananon A; Mekli K; Ollier W; Muir KR
JAMA Netw Open; 2020 Apr; 3(4):e203760. PubMed ID: 32329772
[TBL] [Abstract][Full Text] [Related]
15. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.
Bardia A; Olson JE; Vachon CM; Lazovich D; Vierkant RA; Wang AH; Limburg PJ; Anderson KE; Cerhan JR
Breast Cancer Res Treat; 2011 Feb; 126(1):149-55. PubMed ID: 20669045
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL; Lacey JV; Schatzkin A; Leitzmann MF; Richesson D; Hollenbeck AR; Brinton LA
Breast Cancer Res; 2008; 10(2):R38. PubMed ID: 18447943
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer.
Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G
JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528
[TBL] [Abstract][Full Text] [Related]
18. Vegetarian dietary patterns and the risk of breast cancer in a low-risk population.
Penniecook-Sawyers JA; Jaceldo-Siegl K; Fan J; Beeson L; Knutsen S; Herring P; Fraser GE
Br J Nutr; 2016 May; 115(10):1790-7. PubMed ID: 26987270
[TBL] [Abstract][Full Text] [Related]
19. Low-Dose Aspirin and Prevention of Colorectal Cancer: Evidence From a Nationwide Registry-Based Cohort in Norway.
Nafisi S; Støer NC; Veierød MB; Randel KR; Hoff G; Löfling L; Bosetti C; Botteri E
Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38300127
[TBL] [Abstract][Full Text] [Related]
20. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
